MELANIE KARPMAN: Open Payments
NPI 1720616444 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 124 payments from 16 companies in 2025. Trend: 2023 $1,963 · 2024 $2,434 · 2025 $2,394
Food & beverage: $2,281Education: $113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $386 |
| UCB, Inc. | 14 | $339 |
| Incyte Corporation | 17 | $272 |
| LEO Pharma Inc. | 15 | $268 |
| Lilly USA, LLC | 13 | $252 |
| Novartis Pharmaceuticals Corporation | 12 | $234 |
| Regeneron Healthcare Solutions, Inc. | 6 | $220 |
| GENZYME CORPORATION | 6 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $59 |
| Amgen Inc. | 2 | $52 |
Products named: DUPIXENT, Bimzelx, OPZELURA, ADBRY, SKYRIZI, EBGLYSS, TALTZ, RINVOQ.
Industry payments across IL — which companies pay providers there.
